The global factor Xa inhibitor market is experiencing significant development in the coming years. This phenomenon can be attributed to a increasing prevalence of thromboembolic diseases worldwide, coupled with an aging population. , Moreover, advancements in technology have led to the development of more effective factor Xa inhibitors, increasing